Background In epidemiologic research, little emphasis has been placed on methods to account for left-hand censoring of 'exposures' due to a limit of detection (LOD).
Introduction
In epidemiologic research, emphasis is placed rightly on appropriately accounting for incomplete outcome data due to censoring. 1 For example, methods are commonly employed to account for right-hand censoring of times-to-event due to drop-out or study completion. In addition, analyses of biomarker outcomes due to a limit of detection (LOD) commonly employ methods (for possible mixtures of true zeros) and left-hand censoring at the LOD.
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However, with few exceptions, [11] [12] [13] [14] [15] little emphasis has been placed on principled methods to account for left-hand censoring of biomarker exposures due to an LOD. The LOD is the lowest quantity of a substance that can be distinguished from the absence of the substance. Most analytic instruments produce a signal even when a matrix without the analyte (i.e. a blank) is analysed. The LOD is often estimated as the mean of the blank plus the product of a confidence level (e.g. 99%) and the standard deviation (SD) of the blank. Values below the LOD may indeed be useful (albeit perhaps subject to more measurement error than values above the LOD), but here we assume that such values are not reported by the laboratory, as is common practice. We compare the use of several ad hoc methods to account for an exposure with an LOD when estimating the odds ratio (OR). In particular, we describe an example of estimating the odds of anti-HIV therapy naiveté in HIV-infected men as a function of the plasma HIV RNA viral load. In addition, we describe moderate-and large-sample simulation experiments and provide a summary of simulation results to guide future research.
Methods

Study population
As an example, we calculate the odds of anti-HIV therapy naiveté in 45 HIV-infected heterosexual men as a function of the log 10 plasma HIV RNA viral load. The 45 HIV-infected men have been previously described. 16 Briefly, viral load was ascertained from plasma samples using RNA amplification yielding an LOD of 400 copies/ml of plasma. History of anti-HIV therapy use was obtained by self-report. Identification of particular agents or therapy regimens by self-report may be subject to substantial misclassification, but classification of having ever used any anti-HIV therapy by self-report is likely subject to substantially less misclassification.
Due to the established effectiveness of anti-HIV therapies, 2,17 one would surmise a priori that a high level of viral load would suggest that a patient with established HIV is therapy naïve, although patients receiving anti-HIV therapies that fail or patients that are not adherent may also demonstrate high levels of viral load.
Statistical methods
Data were analysed with logistic regression for the binary outcome therapy naiveté with the log 10 HIV RNA viral load exposure as the sole covariate using five approaches. First, records with values of exposure below the LOD were excluded from analysis. Secondly, the LOD was substituted for exposure values below the LOD. Thirdly, the LOD/ˇ2 was substituted for exposure values below the LOD. Fourthly, the LOD/2 was substituted for exposure values below the LOD. Lastly, a maximum likelihood estimate (MLE) was obtained as described in the following paragraph.
One can find the MLE accounting for an LOD in the exposure. Although the likelihood function has no closed form, it can be expressed through an 1D integral. As is standard with maximum likelihood, 18 given the correct data generating mechanism, the estimates are asymptotically unbiased and efficient. The log likelihood is
where y is an indicator of the event of interest,
with unknown mean m and SD and
This integral must be evaluated numerically. We do so by a Riemann sum, which can approximate q to a chosen level of accuracy. SAS code is provided in Appendix 1, using the NLMIXED procedure to maximize this log likelihood. R code is provided in Appendix 2, using the optim() function to maximize this log likelihood.
Monte Carlo simulation
Six scenarios were studied varying the sample size as moderate (N ¼ 500) or large (N ¼ 2000) and the percent of exposure below the LOD as 25, 50 or 75%. Undetectable percentages as large as 50% may be seen in epidemiologic research on novel biomarkers before great strides are made in the refinement of the assay or measurement. For example, in the mid1990s, when effective therapies for HIV debuted assays for HIV RNA viral load were still in early stages of refinement and often provided large percentages of undetectable measurements for successfully treated individuals. Whereas we would rarely expect to see biomarkers with 75% below the LOD, this scenario is studied to provide a more complete picture. For each scenario, 5000 simulations were generated.
For each simulated subject, a log-normally distributed exposure, X, was generated to have a median of 1 and first and third quartiles of 0.5 and 2.0, respectively. Limits of detection were set at 0.5, 1 and 2 to achieve the desired percents below the LOD. To reflect typical epidemiologic studies, a binary outcome was generated with a marginal incidence of $10%, conditional on the log-normal exposure with an OR of 1.5, which yielded $75 and 499% statistical power in the moderate and large sample settings, respectively.
Simulated data were analysed with logistic regression for the binary outcome with the log-normal exposure as the sole covariate using the same five approaches described for the example as well as the full data. Full data were analysed using true values for exposure below the LOD. This full data approach is not typically available to investigators but is conducted here to provide a reference.
Simulation results are tallied as: percent bias, defined as 100 Â exp 1 À Á =1:5 À 100, where 1 is the average (over simulations) estimated log OR or 5000 À1 ð P 5000 j¼1 b 1,j Þ; Monte Carlo standard error for the log OR, defined as ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
statistical power, defined as the percent of simulations that produce a statistically significant result given a true OR of 1.5, with a two-sided of 0.05; and confidence interval (CI) coverage, defined as the percent of simulations where the 95% CI traps the true OR. A separate simulation study was conducted to assess the validity of the approaches (i.e. type 1 error) using the large sample size and 50% of exposure below the LOD. The simulation standard error for CI coverage or the type 1 error (under the null) was AE0.3%.
Results
Example results
Of 45 men, 23 were non-White and the median age (inter-quartile range, IQR) was 40 (37-46) years. Of 45 men, 10 had infection duration 46 years and 1/3 had an existing AIDS diagnosis. Of 45, 10 had a viral load below the LOD (of 400 copies/ml); among the 35 of 45 with a quantified viral load, the median number of log 10 copies (IQR) was 4.57 (3.68-5.04). The mean log 10 viral load was 4.41 and the skew was -0.36, suggesting (given the limited sample size) a relatively log-normal distribution. Of 45 men, 12 were therapy naïve by self-reports. Figure 1 provides the viral load values by anti-HIV therapy naiveté status. As shown in Table 1 , the estimated OR of being therapy naïve for each log 10 difference in viral load ranged from 1.45 with the MLE to 1.77 with substitution of the LOD. Exclusion and substitution of LOD/2 yielded similar ORs of 1.54 (95% CI 0.61-3.90) and 1.56 (95% CI 0.90-2.69), respectively. Substitution of LOD and LOD/ˇ2 yielded larger ORs of 1.77 (95% CI 0.88-3.56) and 1.64 (95% CI 0.90-2.99), respectively. As expected given the simulation results (see below), relative to the MLE, the ad hoc substitutions provided estimates of the OR that were 8-22% larger than the MLE, and therefore likely biased away from the null in this setting. Also, the ad hoc substitutions provided standard errors that were 36-18% smaller than the MLE. These smaller standard errors were likely overly optimistic given that single deterministic substitutions do not account for the uncertainty in the missing values below the LOD.
Simulation results
As expected, across the six scenarios studied, the use of full data provided an approximately unbiased estimate of the OR with appropriate CI coverage ( Table 2 ). In addition, the MLE provided an unbiased estimate with appropriate CI coverage in all scenarios. The MLE, which accounts for the uncertainty in the missing data, appropriately provided slightly less precision than the full data even when the proportion below the LOD was only 25%. However, when the proportion below the LOD was 75%, the MLE was 430% less efficient than the estimate obtained from the full data. Exclusion of exposures below the LOD was relatively unbiased, but sacrificed precision. For instance, with 50% of exposure below the LOD, exclusion resulted in standard errors approximately twice as those of the full data and was therefore associated with 75% efficiency loss. Substitution of LOD, LOD/ˇ2 or LOD/2 provided estimates of the OR that were increasingly biased as the percent of exposure 
Discussion
We demonstrated that many common ad hoc methods to account for an LOD in an exposure variable are flawed. Use of the MLE appeared unbiased, appropriately precise (relative to the full data) and provided appropriate CI coverage and type 1 error. While exclusion of exposures below the LOD was unbiased, it was only unbiased in these settings because the effect of exposure on outcome was constant across the range of exposure. 19 Moreover, a great loss in precision may accompany exclusion of values below the LOD: a portion of this information may be recovered using the MLE. The example analysis supported simulation results, but is based on a small study of 45 HIVinfected men.
Existing work on left-or interval-censored exposures is scarce. Lynn 11 compared several ad hoc substitutions, a maximum likelihood approach and several multiple-imputation approaches using the example of left-censored HIV viral load as an exposure for incident AIDS as well as simulations. Lynn found the maximum likelihood approach operated best (i.e. smallest mean squared error). Gomez et al. 13 derived MLEs for a discrete-valued intervalcensored baseline characteristic in a randomized trial, and demonstrated by simulation that midpoint substitution is flawed. Richardson and Ciampi 12 discussed the setting where a left-censored exposure is subject to measurement error, they suggested substitution of the expectation below the LOD will provide unbiased estimates and they describe simulations demonstrating that standard results for nondifferential, independent measurement error may not apply in the presence of a left-censored exposure. Schisterman et al.
14 developed a substitution method for handling left-censored exposures in linear and logistic regression with a nutritional biomarker example and simulations: the authors concluded that replacing values below the LOD with the expectation 'above' the LOD provided unbiased estimates while overcoming the distributional assumptions of other methods. Lei et al. 15 provided a likelihood-based framework that incorporates the approaches of Richardson and Ciampi 12 and Schisterman et al. 20, 21 one could fit the analogy of a two-part model, such as a binary indicator for being below the LOD and a continuous regressor for values above the LOD. In such extensions, as in the approach described here, the choice of parametric distribution for exposure values (or values above 0 or the LOD in the mixture or two-part model, respectively) is crucial. Therefore, thorough exploratory data analysis and information from subject-matter specialists are essential.
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One can envision the ad hoc solutions studied, e.g. substitution of LOD/2, LOD/ˇ2 and the LOD itself as points along a continuum of possible values for the left-censored exposures. Therefore, it is reasonable that the bias is a function of the substituted value. Indeed, if one were able to plug-in the expectation of exposure below the LOD for values below LOD, the resultant estimate would be approximately unbiased. 12 However, in practice, one will not typically know the expectation of exposure below the LOD and therefore not be able to simply calibrate the substitution value to remove bias (although once a parametric form is specified for the likelihood, one could calculate this expectation in principle). Even if one were able to simply calibrate such a substitution, the resultant interval estimate would be overly precise due to not accounting for the uncertainty in the calibration.
However, it should be noted that substitution of the LOD/2 worked fairly well in simulations with 450% exposure data below the LOD. This is the case here because the expectation of exposure below the LOD (SD) was $0.3 (0.12), 0.5 (0.25) and 0.8 (0.5) for 25, 50 and 75% of exposure below the LOD, respectively. Therefore, at an LOD of 0.5, and of the substitutions explored, LOD/ˇ2 ¼ 0.35 will best mimic the expectation below the LOD; at an LOD of 1, substitution of LOD/2 ¼ 0.5 will best mimic the expectation below the LOD; and at an LOD of 2, substitution of LOD/ 2.5 ¼ 0.8 (not explored) would have best mimicked the expectation below the LOD.
Whereas these simulations typified data seen in epidemiologic research (albeit enriching the percent below the LOD), more empirical examples are warranted. A limitation of maximum likelihood is its possible sensitivity to incorrect specification of the model for the data: this in particular could be explored in future work. In addition to maximum likelihood, multiple-imputation 22 and Bayesian 23 methods should also be explored in more detail. Indeed, multiple-imputation provides MLEs when data are missing at random and the imputation model form is correct. 22 However, it should be noted that simply multiplying imputing values from a uniform distribution below the LOD will only provide unbiased results if the uniform distribution correctly reflects the distribution of biomarker values below the LOD, which is unlikely in epidemiologic settings. In conclusion, in the settings explored and among methods typically available to investigators (i.e. sans full data or substitution of expectation of exposure below the LOD), many ad hoc approaches to handling exposures subject to an LOD are flawed. However, maximum likelihood provides an unbiased and appropriately precise estimate of the exposure-outcome association.
KEY MESSAGES
Little emphasis has been placed on principled methods to account for left-hand censoring of biomarker exposures due to a limit of detection (LOD).
Ad hoc methods to account for an exposure LOD are flawed.
Maximum likelihood methods are unbiased and appropriately precise.
